Technical Analysis for KMPH - KemPharm, Inc.

Grade Last Price % Change Price Change
grade F 0.9799 -2.98% -0.03
KMPH closed down 2.98 percent on Friday, August 16, 2019, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical KMPH trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction -2.98%
Lower Bollinger Band Walk Weakness -2.98%
Stochastic Reached Oversold Weakness -2.98%
Inside Day Range Contraction -2.98%

Older signals for KMPH ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
Basic chart:
Profile
KemPharm is a specialty pharmaceutical company focused on the discovery and development of NME prodrugs to treat serious medical conditions through its Ligand Activated Therapy (LAT) platform technology. KemPharm utilizes its LAT platform technology to generate improved prodrug versions of FDA-approved drugs in the high needs areas of pain, ADHD and other CNS disorders.
Health Pharmaceutical Pharmaceutical Industry Pain Medication FDA Pharmacokinetics Platform Technology Attention Deficit Hyperactivity Disorder Adhd Amphetamine Methylphenidate
Is KMPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Aug 13 KemPharm EPS beats by $0.10
Aug 13 KemPharm Reports Second Quarter 2019 Results
Aug 11 The Week Ahead In Biotech: Vanda Awaits FDA Decision, BioVie Plans IPO
Aug 7 Implied Volatility Surging for KemPharm (KMPH) Stock Options
Aug 5 ALLK, DO, GFI and SA among midday movers
Jun 19 Benzinga's Top Upgrades, Downgrades For June 19, 2019
May 14 KemPharm misses by $0.04
May 14 KemPharm Reports First Quarter 2019 Results
May 8 The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split
May 3 The Daily Biotech Pulse: Obseva Reports Positive Endometriosis Drug Trial, Assembly Biosciences Execs Depart, Coherus Settles With Amgen
See more KMPH news...
Indicators
Indicator Value
52 Week High 5.47
52 Week Low 0.96
Average Volume 143,697
200-Day Moving Average 1.9316
50-Day Moving Average 1.4569
20-Day Moving Average 1.2407
10-Day Moving Average 1.1735
Average True Range 0.1152
ADX 19.93
+DI 14.7983
-DI 31.8063
Chandelier Exit (Long, 3 ATRs ) 1.3744
Chandelier Exit (Short, 3 ATRs ) 1.3056
Upper Bollinger Band 1.5197
Lower Bollinger Band 0.9617
Percent B (%b) 0.03
BandWidth 44.974611
MACD Line -0.1212
MACD Signal Line -0.0992
MACD Histogram -0.022
Fundamentals Value
Market Cap 14.36 Million
Num Shares 14.7 Million
EPS -3.10
Price-to-Earnings (P/E) Ratio -0.32
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.05
Resistance 3 (R3) 1.06 1.03 1.04
Resistance 2 (R2) 1.03 1.01 1.03 1.04
Resistance 1 (R1) 1.01 1.00 0.99 1.00 1.03
Pivot Point 0.98 0.98 0.98 0.98 0.98
Support 1 (S1) 0.96 0.96 0.94 0.95 0.93
Support 2 (S2) 0.93 0.95 0.93 0.92
Support 3 (S3) 0.91 0.93 0.92
Support 4 (S4) 0.90